Mirae Asset Global ETFs Holdings
SUPN icon

Mirae Asset Global ETFs Holdings’s Supernus Pharmaceuticals SUPN Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Sell
25,752
-155
-0.6% -$7.44K ﹤0.01% 1546
2026
Q1 		$1.34M Buy
25,907
+854
+3% +$43.5K ﹤0.01% 1377
2025
Q4 		$1.25M Buy
25,053
+86
+0.3% +$4.18K ﹤0.01% 1399
2025
Q3 		$1.19M Sell
24,967
-4,601
-16% -$185K ﹤0.01% 1383
2025
Q2 		$932K Sell
29,568
-292
-1% -$9.36K ﹤0.01% 1479
2025
Q1 		$978K Buy
29,860
+1,297
+5% +$46K ﹤0.01% 1510
2024
Q4 		$1.03M Buy
28,563
+1,083
+4% +$38.1K ﹤0.01% 1524
2024
Q3 		$857K Buy
27,480
+3,075
+13% +$96K ﹤0.01% 1626
2024
Q2 		$653K Buy
+24,405
New +$707K ﹤0.01% 1689

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's SUPN Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Supernus Pharmaceuticals (SUPN) stake by 0.6% in Q2 2026, selling an estimated $7.44K and leaving 25,752 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1546.

Mirae Asset Global ETFs Holdings first reported a position in SUPN in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.34M in Q1 2026. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 25,752 shares of Supernus Pharmaceuticals worth $1.2M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 155 Supernus Pharmaceuticals shares in Q2 2026, an estimated $7.44K.
  • Supernus Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1546 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Supernus Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Supernus Pharmaceuticals position peaked at $1.34M in Q1 2026.
  • 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.